Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRTX | GSK | REGN | ||
| Company | Vertex Pharmaceutic | Gsk Plc ADR | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 436.25 | 57.03 | 765.26 | ||
| High | 443.99 | 57.41 | 775.63 | ||
| Low | 432.33 | 56.51 | 755.99 | ||
| Latest | 443.92 | 57.37 | 775.53 | ||
| Change | +12.06 | +1.53 | +15.26 | ||
| % Change | +2.79% | +2.74% | +2.01% | ||
| Volume | 1,279,200 | 3,809,500 | 580,400 | ||
| 20-Day Average Volume | 1,430,760 | 4,448,195 | 605,390 | ||
| Previous Close | 431.86 | 55.84 | 760.27 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 452.97 | 54.27 | 753.97 | ||
| 20-Day Raw Stochastic | 25.14% | 99.32% | 86.26% | ||
| 20-Day Relative Strength | 45.44 | 58.78 | 53.68 | ||
| Weighted Alpha | -4.58 | +65.29 | +42.46 | ||
| Today's Opinion | 8% Buy | 80% Buy | 64% Buy | ||
| Previous Opinion | 24% Sell | 72% Buy | 48% Buy | ||
| Last Month's Opinion | 64% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.59% since 03/31/26 | +3.95% since 03/31/26 | +0.37% since 03/31/26 | ||
| Low | 425.26 on 04/07/26 | 55.11 on 04/07/26 | 745.00 on 04/02/26 | ||
| High | 453.98 on 04/01/26 | 57.41 on 04/08/26 | 781.21 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | -2.80% since 03/06/26 | +5.25% since 03/06/26 | +2.06% since 03/06/26 | ||
| Low | 425.26 on 04/07/26 | 51.54 on 03/20/26 | 727.88 on 03/19/26 | ||
| High | 507.92 on 03/10/26 | 57.41 on 04/08/26 | 788.69 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | -5.48% since 01/08/26 | +14.24% since 01/08/26 | -3.18% since 01/08/26 | ||
| Low | 425.26 on 04/07/26 | 47.62 on 01/20/26 | 718.38 on 01/20/26 | ||
| High | 507.92 on 03/10/26 | 61.69 on 02/18/26 | 821.11 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +5.41% since 10/08/25 | +32.34% since 10/08/25 | +37.54% since 10/08/25 | ||
| Low | 402.58 on 10/13/25 | 42.85 on 10/24/25 | 541.00 on 10/13/25 | ||
| High | 507.92 on 03/10/26 | 61.69 on 02/18/26 | 821.11 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 112,915,488 | 116,545,840 | 81,989,040 | ||
| Shares Outstanding, K | 254,360 | 2,031,477 | 105,720 | ||
| Annual Sales | 12,001,300,000 | 43,077,970,000 | 14,342,900,000 | ||
| Annual Net Income | 3,953,200,000 | 7,537,690,000 | 4,504,900,000 | ||
| Last Quarter Sales | 3,190,000,000 | 11,424,970,000 | 3,884,300,000 | ||
| Last Quarter Net Income | 1,191,100,000 | 851,670,000 | 844,600,000 | ||
| 60-Month Beta | 0.36 | 0.46 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 5.03 on 02/12/26 | 0.68 on 02/04/26 | 11.44 on 01/30/26 | ||
| Latest Earnings Date | 05/04/26 | 04/29/26 | 04/29/26 | ||
| Most Recent Dividend | N/A | 0.478 on 02/20/26 | 0.940 on 02/20/26 | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 26.30 | 12.35 | 21.07 | ||